Immupharma Share Discussion Threads

[113mike] 09/1/2018 14:53

13% down just today so far.bet those who bought in on the back SCSW weekend tip are thrilled!

[adejuk] 09/1/2018 14:52

the mm went short and are balancing the book

[qs99] 09/1/2018 14:51

If this is not unblinded until next week then this looks an odd fall does it not? Quite extreme and unless we see a retrace is it all MMs "playing games" as some are suggesting? Why sell now, why not wait until results are out?

[aimingupward2] 09/1/2018 14:14

ashehzi, you have been given a good response by hamhamham but why, for goodness sake, ask the question here when you could perfectly well google it and get an immediate and much fuller answer to your query?

[hamhamham1] 09/1/2018 12:46

re. SCSW - seems they have 2 newsletters, I think it was a nap in the first one?

SCSW
The Small Company Sharewatch (SCSW), launched in 1993, is a stockmarket newsletter which concentrates on small, dynamic growth shares. The most persuasive reason for subscribing is the performance of our selections. The basic technique is simple - to search for "something new" that will trigger a rerating, whether it be a product, an acquisition, an event or a change in management.

TMI
Published each year since 1998, The Momentum Investor (TMI) is an independent monthly newsletter that alerts you to outstanding investment opportunities. We look at those shares which are showing relative strength against the market and have earnings that are growing very quickly, say 25% a year and whose earnings continually surprise the City by being higher than expected.

[top tips] 09/1/2018 12:32

Hope you all kept some money back for top ups today. Market makers playing a blinder but its a bargain if teh results are OK.

[l0ngterm] 09/1/2018 12:20

IMM went with northland not finncapp. http://www.immupharma.co.uk/wp-content/uploads/2017/09/Immupharma-interims-June-2017-booklet-1.pdf

[albanyvillas] 09/1/2018 12:18

Panmure only negative cos they were fired and IMM went to Fincap

[ny boy] 09/1/2018 12:17

All you can do whilst waiting for the results is to add on decent opportunities, like the expected retrace to 150p support.

Rinse & repeat, this has happened a few times and each time the share price breaks higher, bear trap earlier

GLA expecting 200-250p before any news-flow.

[l0ngterm] 09/1/2018 12:17

Spawny: Panmure have had for ages a buy with a 1.00 price target. We passed this a while back. Panmure have subsequntly then stated 1.00 price target with a sell.So No change on panmures target price. Personally I have ignored panmures price target from day 1. I was also not to impressed with them when they were nomad for IMM. As the new nomad has demonstrated more involvement, but this is from my PI perspective and may not be fair on Panmure.

[hamhamham1] 09/1/2018 12:13

Small Company Share Watch

[ashehzi] 09/1/2018 12:08

What does SCSW stand for? Heard it before here and also on LSE. Please clarify. Thanks.

[albanyvillas] 09/1/2018 12:07

Too many unrealistic expectations set here This won't get to £200 a share i feel but it might get to about £80

:)

[spawny100] 09/1/2018 12:05

Has the downgrade been confirmed and a valid link posted? I can't find anything on it nw99.

[volsung] 09/1/2018 11:51

Wouldn't put anything past MMs hamham. They're here to make as much as they can for themselves and their big clients

[hamhamham1] 09/1/2018 11:49

Again, the cynic inside me thinks it as an orchestrated shake.
News over the weekend that SCSW have named Immupharma as one of its top 2018 naps.
This would have cause a certain percentage of fresh buyers to buy in yesterday.
A percentage of these would have set a 10-20% stop loss (new to this share etc).
Knowing these entry prices (and that they are likely new buyers with no lower average to rely on) and the known time of buying can make PI's cannon fodder for MMs.
Maybe it's just me :)

[sportbilly1976] 09/1/2018 11:48

wait for a chunk trade to show later which was conveniently filled around 152-155 :)

imo

[aussieb3] 09/1/2018 11:48

Big buys coming in now

[volsung] 09/1/2018 11:47

I like it when there's big falls on shares I'm well ahead on. 9 times out of 10 they recover well but even if they don't there's a nice cushion of profit

[allonblack] 09/1/2018 11:30

What is relevant when coming up with these offer valuations is not just peak revenue but cost of production, dosage and margins. Lupuzor is cheap to produce, very low dosage and very high margin. Ablynx would have a 50pc margin on the main drug. So if anything Lupuzor is worth more than Benlysta or the Ablynx drug. This all boils down to the results. If they are good, in the current environment, this company wont have a modest valuation.

[dibs61] 09/1/2018 11:27

The Panmure note plus getting close to results plus big share price rise over recent months.

All have conspired to cause an outbreak of squeaky bum time for investors.

Lots of trading going on too imv.

It’s simple,you either believe or you don’t.

I see this as an opportunity not a reason to run for the door.

[talkman2] 09/1/2018 11:21

I never have a guaranteed stop loss The market knows they are there . Especially when it wants stock .